Poket News

Bangladeshi COVID vaccine gets ethical permission for human trial

 

  • The indigenously developed Bangavax covid vaccine has received the ethical permission from the Bangladesh Medical Research Council (BMRC) to start the human trial.
  • The vaccine developed by the local Bangladeshi pharmaceutical company Globe Biotech Limited completed the trial on animals as required by the BMRC to grant permission for human trials. 
  • The company will now submit an application to the Directorate General of Drug Administration (DGDA) seeking its permission for the clinical trials.